Search





Search





Markets
/
Stocks
/
hscs
/

HeartSciences Inc

HSCS

Add to Watchlist

2.320USD

+0.240+11.54%

Close 07-31 16:00（ET）Quotes delayed by 15 min

7.40MMarket Cap

LossP/E TTM

HeartSciences Inc

2.320

+0.240+11.54%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

HSCS Cash Flow Statement

You can access the annual and quarterly cash flow statements of HeartSciences Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q4

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q2

FY2022Q1

FY2021Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-5.40%-1.68M

9.73%-1.46M

-6.90%-2.33M

3.24%-1.95M

-3.53%-1.59M

24.34%-1.62M

-120.97%-2.18M

-43.76%-2.02M

17.47%-1.54M

-109.93%-2.14M

8.51%-988.19K

22.49%-1.40M

-56.14%-1.86M

---1.02M

-40.63%-1.08M

-152.51%-1.81M

-65.45%-1.19M

---768.05K

---717.49K

---720.64K

Net income from continuing operations

-31.35%-2.75M

21.73%-1.99M

-12.86%-2.35M

-0.16%-2.05M

-13.44%-2.09M

-54.29%-2.54M

-19.13%-2.08M

-50.10%-2.05M

-13.10%-1.85M

-22.48%-1.64M

3.22%-1.75M

13.12%-1.37M

20.49%-1.63M

---1.34M

-74.58%-1.81M

-213.50%-1.57M

-141.10%-2.05M

---1.03M

---501.85K

---851.57K

Operating gains losses

9954.00%755.36K

15.13%6.92K

-42.64%7.01K

-40.06%7.11K

-18.35%7.51K

61.61%6.01K

59.97%12.21K

61.68%11.86K

34.81%9.20K

-45.86%3.72K

12.08%7.64K

14.44%7.34K

5.06%6.83K

--6.87K

3.21%6.81K

-8.05%6.41K

-10.42%6.50K

--6.60K

--6.97K

--7.25K

Other non-cash items

-56.48%128.08K

-4.92%126.37K

261.69%318.88K

327.03%134.51K

75.97%294.29K

7.41%132.91K

-72.05%88.17K

--31.50K

10.52%167.24K

--123.74K

--315.49K

100.00%0.00

-16.23%151.33K

--0.00

92.03%-19.82K

--180.66K

--0.00

---248.59K

--0.00

Change in working capital

-226.41%-133.92K

-98.16%13.30K

-203.89%-746.27K

-230.35%-214.56K

92.98%105.94K

200.19%722.47K

-174.14%-245.57K

61.66%-64.95K

111.28%54.90K

-329.86%-721.09K

-53.85%331.23K

54.31%-169.39K

-167.26%-486.65K

--313.71K

176.78%717.64K

-1619.66%-370.72K

506.97%723.52K

--259.28K

--24.39K

--119.20K

-Change in receivables

100.00%0.00

--0.00

--4.35K

-129.59%-4.35K

----

--14.70K

---10.80K

---3.90K

-100.00%0.00

100.00%0.00

--0.00

--2.32K

---2.32K

--0.00

-Change in inventory

-11.91%1.66K

-100.00%0.00

21.18%-7.78K

105.48%760.00

-95.43%1.88K

-83.34%760.00

-749.21%-9.87K

---13.86K

7372.55%41.10K

500.13%4.56K

--1.52K

100.00%0.00

417.92%550.00

--760.00

-100.00%0.00

-110.49%-3.53K

-100.43%-173.00

--23.40K

--33.66K

--40.34K

-Change in prepaid expenses

-15.63%98.88K

635.30%257.30K

-112.44%-20.57K

-344.43%-97.75K

229.97%117.19K

-73.77%34.99K

55.28%165.33K

-54.16%39.99K

-178.15%-90.17K

21.27%133.40K

-18.71%106.47K

196.59%87.23K

56.95%115.39K

--110.00K

273.43%130.98K

109.80%29.41K

1267.35%73.52K

---75.52K

--14.02K

---6.30K

-Change in other current assets

-314.59%-862.80K

---258.42K

---198.70K

----

895.50%402.06K

----

--40.39K

---40.39K

----

--0.00

-Change in other current liabilities

195.05%531.28K

-120.52%-116.71K

-367.71%-189.67K

-862.42%-224.90K

-1394.11%-558.93K

1910.90%568.77K

88.09%-40.55K

127.36%29.50K

78.74%-37.41K

---31.41K

---340.42K

-145.62%-107.83K

-1024.81%-175.92K

--0.00

--236.35K

---15.64K

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-5.40%-1.68M

9.73%-1.46M

-6.90%-2.33M

3.24%-1.95M

-3.53%-1.59M

24.34%-1.62M

-120.97%-2.18M

-43.76%-2.02M

17.47%-1.54M

-109.93%-2.14M

8.51%-988.19K

22.49%-1.40M

-56.14%-1.86M

---1.02M

-40.63%-1.08M

-152.51%-1.81M

-65.45%-1.19M

---768.05K

---717.49K

---720.64K

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

77.49%27.87K

169.94%15.77K

-2.28%814.00

-92.87%7.81K

78.54%15.70K

199.28%5.84K

-83.03%833.00

1343.82%109.61K

153.50%8.79K

--1.95K

-32.25%4.91K

--7.59K

--3.47K

-100.00%0.00

--7.25K

-100.00%0.00

--1.93K

--0.00

--712.00

Capital expenditures

-100.00%0.00

137.84%37.34K

169.94%15.77K

-2.28%814.00

-92.87%7.81K

78.54%15.70K

199.28%5.84K

-83.03%833.00

1343.82%109.61K

153.50%8.79K

--1.95K

-32.25%4.91K

--7.59K

--3.47K

-100.00%0.00

--7.25K

-100.00%0.00

--1.93K

--0.00

--712.00

Net cash flow from disposal of fixed assets

--0.00

---9.48K

460.67%13.03K

----

-100.00%0.00

19.06%2.32K

-83.03%833.00

542.77%48.80K

153.50%8.79K

--1.95K

-32.25%4.91K

--7.59K

--3.47K

-100.00%0.00

--7.25K

-100.00%0.00

--1.93K

--0.00

--712.00

Net cash flow from intangible asset transactions

-100.00%0.00

137.84%37.34K

-22.11%2.74K

--814.00

-87.15%7.81K

--15.70K

--3.52K

----

--60.82K

----

Net cash flow from other investing activities

--0.00

---13.03K

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

100.00%0.00

-77.49%-27.87K

-169.94%-15.77K

2.28%-814.00

92.87%-7.81K

-78.54%-15.70K

-199.28%-5.84K

83.03%-833.00

-1343.82%-109.61K

-153.50%-8.79K

---1.95K

32.25%-4.91K

---7.59K

---3.47K

100.00%0.00

---7.25K

100.00%0.00

---1.93K

--0.00

---712.00

Financing cash flow

Cash flow from continuous financing activities

-163.66%-63.67K

1529.60%2.94M

-20.66%1.51M

561.31%3.65M

-73.48%100.03K

-98.03%180.19K

269.53%1.90M

70.08%551.68K

-76.41%377.14K

7610.17%9.13M

542.15%514.63K

-93.73%324.36K

104.35%1.60M

---121.52K

-110.26%-116.39K

--5.17M

60.82%782.37K

--1.13M

--0.00

--486.50K

Net cash flow from debt Issuance/repayment

10.63%-63.67K

4221.22%2.94M

-123.41%-416.76K

-184.39%-148.06K

3.77%-71.25K

-41.27%-71.25K

1888.41%1.78M

22.97%-52.06K

39.08%-74.04K

58.50%-50.43K

14.46%-99.56K

-74.21%-67.59K

-115.38%-121.54K

---121.54K

-118.16%-116.39K

---38.80K

62.38%790.00K

--641.00K

--0.00

--486.50K

Net cash flow from common stock issuance/repurchase

-100.00%0.00

42.70%172.84K

----

-62.04%171.28K

-97.28%251.44K

-56.73%121.12K

54.04%603.75K

-73.77%451.18K

--9.23M

--279.94K

-92.45%391.95K

--1.72M

--0.00

--5.19M

----

--0.00

Net cash flow from preferred stock issuance/repurchase

--0.00

--1.75M

--3.80M

----

--0.00

----

--0.00

Proceeds from stock option exercised by employees

----

--0.00

----

--0.00

--14.00

----

Proceeds from issuance of warrants

----

--0.00

-100.00%0.00

--0.00

--17.25K

----

--0.00

----

Net cash flow from other financing activities

--0.00

--3.00M

--172.84K

--0.00

----

--0.00

---54.84K

--334.25K

----

100.00%0.00

--0.00

-100.00%0.00

----

---7.63K

--493.37K

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-163.66%-63.67K

1529.60%2.94M

-20.66%1.51M

561.31%3.65M

-73.48%100.03K

-98.03%180.19K

269.53%1.90M

70.08%551.68K

-76.41%377.14K

7610.17%9.13M

542.15%514.63K

-93.73%324.36K

104.35%1.60M

---121.52K

-110.26%-116.39K

--5.17M

60.82%782.37K

--1.13M

--0.00

--486.50K

Net cash flow

Beginning cash balance

30.83%3.40M

-51.85%1.95M

-35.66%2.79M

-81.09%1.10M

-63.31%2.60M

3946.29%4.05M

653.89%4.34M

249.76%5.81M

266.48%7.08M

-96.74%100.14K

-86.53%575.65K

80.83%1.66M

45.38%1.93M

--3.08M

71227.20%4.27M

26.92%918.26K

38.60%1.33M

--5.99K

--723.48K

--958.33K

Current period cash flow changes

-16.14%-1.74M

199.34%1.45M

-192.41%-841.13K

215.41%1.69M

-18.09%-1.50M

-120.86%-1.46M

39.51%-287.66K

-35.31%-1.47M

-369.10%-1.27M

709.28%6.98M

60.26%-475.51K

-132.34%-1.08M

34.02%-270.49K

---1.15M

-428.37%-1.20M

567.50%3.35M

-74.56%-409.95K

--364.39K

---717.49K

---234.85K

Ending cash balance

50.88%1.66M

30.83%3.40M

-51.85%1.95M

-35.66%2.79M

-81.09%1.10M

-63.31%2.60M

3946.29%4.05M

653.89%4.34M

249.76%5.81M

266.48%7.08M

-96.74%100.14K

-86.53%575.65K

80.83%1.66M

--1.93M

730.49%3.08M

71227.20%4.27M

26.92%918.26K

--370.38K

--5.99K

--723.48K

Free cash flow

-4.89%-1.68M

8.31%-1.50M

-7.34%-2.35M

3.24%-1.95M

2.89%-1.60M

23.92%-1.64M

-121.12%-2.19M

-43.31%-2.02M

11.95%-1.65M

-110.08%-2.15M

8.33%-990.14K

22.53%-1.41M

-56.78%-1.87M

---1.02M

-40.28%-1.08M

-153.52%-1.82M

-65.29%-1.19M

---769.99K

---717.49K

---721.35K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did HeartSciences Inc Generate?



HeartSciences Inc generated -7.43M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did HeartSciences Inc's Operating Cash Flow Change Year Over Year?



HeartSciences Inc's operating cash flow increased by -0.18% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does HeartSciences Inc Spend on Capital Expenditures?



HeartSciences Inc spent 44.45K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has HeartSciences Inc's Financing Cash Flow Changed?



HeartSciences Inc used 8.03M in financing activities in the latest quarter.

What is free cash flow and why does it matter for HSCS?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was HeartSciences Inc’s free cash flow in the latest quarter?



Free cash flow was -7.47M reflecting a -0.38% change from the previous year.